| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $61.3M | +10.8% |
| R&D Expense | $525.2M | +8.7% |
| SG&A Expense | $600.5M | -22.5% |
| Operating Income | -$1.18B | +13.0% |
| Interest Expense | $28.0M | +297.2% |
| Pre-tax Income | -$1.22B | -32.6% |
| Income Tax | $5.2M | +1306.5% |
| Net Income | -$1.01B | -19.4% |
| EPS (Basic) | -$1.42 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.68B | -18.6% |
| Accounts Receivable | $30.4M | +683.4% |
| Inventory | $2.8M | — |
| Current Assets | $1.80B | -16.2% |
| Total Assets | $2.39B | -7.6% |
| Current Liabilities | $272.4M | +47.8% |
| Long-term Debt | $375.5M | +78.8% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$843.4M | -24.4% |
| Capital Expenditures | $12.7M | -27.2% |
| Investing Cash Flow | -$44.3M | -114.6% |
| Financing Cash Flow | $499.5M | +62.8% |
| Free Cash Flow | -$856.1M | -23.1% |
| -12.7% |
| EPS (Diluted) | -$1.42 | -12.7% |
| Total Liabilities |
| $782.0M |
| +49.3% |
| Stockholders' Equity | $1.16B | -30.1% |